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ABSTRACT
Objective To examine the prevalence, correlates 
and sociodemographic inequalities of undiagnosed 
hypertension in Nepal.
Design This study used cross- sectional 2016 
Nepal Demographic and Health Survey (NDHS) data. 
Undiagnosed patients with hypertension were defined as 
an NDHS respondent who was diagnosed as hypertensive 
(systolic blood pressure ≥140 mmHg and/or diastolic 
blood pressure ≥90 mmHg) during the survey, but never 
took any prescribed anti- hypertensive medicine to lower/
control blood pressure and was never identified as having 
hypertension by a health professional prior the survey. 
Multiple binary logistic regression analysis was performed, 
and Concentration Index was measured.
Setting Nepal.
Participants Adult patients with hypertension.
Results Among 3334 patients with hypertension, 50.4% 
remained undiagnosed during the survey in Nepal. Adjusted 
model reveals that patients who were male, belonged to 
households other than the highest wealth quintile, and 
lived in province 4 and province 5 were at higher risk of 
remaining undiagnosed for hypertension. Patients who 
were ≥65 years of age and were overweight/obese were at 
lower risk of remaining undiagnosed for hypertension. The 
poor- rich gap was 24.6 percentage points (Q1=64.1% vs 
Q5=39.6%) and poor:rich ratio was 1.6 (Q1/Q5=1.6) in 
the prevalence of undiagnosed hypertension. Undiagnosed 
hypertension was disproportionately higher among lower 
socioeconomic status groups (Concentration Index, 
C=−0.18). Inequalities in the prevalence of undiagnosed 
hypertension further varied across other geographic 
locations, including place of residence, ecological zones 
and administrative provinces.
Conclusions Undiagnosed hypertension was highly 
prevalent in Nepal and there were substantial inequalities 
by sociodemographics and subnational levels. Increasing 
awareness, strengthening routine screening to diagnose 
hypertension at primary health service facilities and 
enactment of social health insurance policy may help 
Nepal to prevent and control this burden.
INTRODUCTION
Hypertension, or raised blood pressure, 
is a leading cause of global mortality and 
disability,1 affecting over one billion people 
annually.2 Hypertension is a directing factor 
for cardiovascular diseases (CVDs), in partic-
ular heart diseases, myocardial infarctions, 
kidney failure, strokes, disability and prema-
ture deaths.2 3 In South- East Asian countries, 
hypertension affects approximately one in 
three adults, accounting for nearly 1.5 million 
deaths annually and contributing to 9.4% of 
total deaths.4 In South- East Asian countries, 
more than 50% of people with hypertension 
remain undiagnosed.5 Nepal has one of the 
highest prevalence rates of hypertension 
among South- East Asian countries.6
Currently, Nepal is facing an epidemiolog-
ical transition with an increasing prevalence 
of hypertension.7 A study based on the Nepal 
Demographic and Health Survey (NDHS) 
2016 reported about 20% of Nepalese 
adults (aged ≥18 years) had hypertension.8 
However, other studies have reported that the 
prevalence of hypertension ranges from 23% 
Strengths and limitations of this study
 ► This study determined the prevalence and correlates 
of undiagnosed hypertension in Nepal using the 
most updated, population- based, nationally repre-
sentative data.
 ► This study measured both wealth- based absolute 
and relative inequalities in the prevalence of undi-
agnosed hypertension at national level as well as 
across place of residence, ecological zones and ad-
ministrative provinces.
 ► The cross- sectional nature of the data limits us to 
measure the causal association between undiag-
nosed hypertension and the explanatory variables 
studied.
 ► The association of some potential behavioural or 
lifestyle factors such as physical activity, dietary 
patterns and family history with undiagnosed hyper-
tension remains unmeasured due to lack of avail-
able data.
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to 34% in Nepal,7 9–12 although not all of these studies are 
representative of the present day Nepalese population. 
In 2013, the national non- communicable disease (NCD) 
risk factor survey showed that while 25.7% of adults aged 
15–69 years had hypertension in Nepal, a further 42.7% 
of adults had never measured their blood pressure.13 
Correct diagnoses of hypertension is prerequisite to the 
prevention, control and proper treatment of this disease. 
In addition, failure to diagnose and treat hypertension 
early may lead to serious health hazards, disability in later 
life or eventually death. In Nepal, a number of govern-
ment, non- government and private health facilities are 
providing health services, such as diagnosis, medication 
and treatment for hypertension. However, owing to chal-
lenges with workforce capacity, resourcing of healthcare 
facilities and out- of- pocket costs incurred by patients, 
the current healthcare system in Nepal is not adequately 
prepared to support the diagnosis, treatment and control 
of hypertension.14
To prevent hypertension, the disease first needs to 
be diagnosed before any related complications arise. 
However, there is a lack of evidence about the prevalence 
of undiagnosed hypertension in Nepal at national and 
subnational levels. Information on the estimates of undi-
agnosed hypertension, and its related sociodemographic 
inequalities, at national and subnational level may 
assist policy makers in formulating effective strategies 
for screening, treatment and control as well as preven-
tion of hypertension and associated burdens of disease, 
particularly among vulnerable groups. As such, we aimed 
to examine the prevalence, correlates and sociodemo-
graphic inequalities of undiagnosed hypertension in 
Nepal.
METHODS
Data source
We used the most updated nationally representative 
cross- sectional data from NDHS. While the data of Demo-
graphic and Health Surveys is managed by Measure 
Evaluation, the NDHS was conducted from June 2016 to 
January 2017 by a private research organisation named 
‘New Era’ under the monitoring and supervision of the 
Ministry of Health, Nepal. To estimate the prevalence 
of hypertension nationally in Nepal, the NDHS 2016 
obtained informed consent from the household head on 
behalf of all household members of each surveyed house-
hold.15 For academic and scientific purposes, this anony-
mous dataset without any identifiers was made available 
by the ICF International, Maryland, USA.15 We obtained 
approval to access and use these data to conduct this 
study.
Survey procedure and participants
In 2015, Nepal reformed and restructured municipality 
boundaries resulting in seven administrative provinces 
comprising several districts and urban–rural areas with 
smaller administrative units known as wards.8 With 
comparatively greater household numbers, urban areas 
were further divided into enumeration areas (EAs). The 
primary sampling units (PSUs) were wards, for both 
urban and rural areas.15 Because of some changes in 
administrative areas, Nepal revised the sampling frame 
of National Population and Housing Census. The 2016 
NDHS used this revised sampling frame and applied a 
multistage survey which was conducted in two and three 
stages across rural and urban areas, respectively. NDHS 
selected the PSUs proportionately to the size in the first 
stage and then the random selection of EAs from the 
systematic selection of households from each PSU in the 
second stage. In the third stage, the households were 
selected by using a stratified cluster sampling technique 
in urban areas. A detailed description of the methodology 
is available elsewhere.15 A total of 11 490 households were 
selected from 383 wards, of which 5520 households from 
184 wards were from urban settings and 5970 households 
from 199 wards were from rural settings. From these 
households, all the residents aged 15 years or above were 
eligible for blood pressure measurement. With an overall 
response rate of 95%, a total of 14 823 individuals partici-
pated in the survey. This study uses an analytical sample of 
adults (>15 years) with hypertension (n=3334). Figure 1 
illustrates the procedure for selecting the study sample.
Outcome variable
To measure hypertension, the 2016 NDHS used the 
UA‐767F/FAC (A&D Medical) automated device to 
record the blood pressure of the participants. With 5 min 
intervals between each measurement, the 2016 NDHS 
recorded the measurements of blood pressure three 
times in a sitting position. NDHS considered the last two 
measures of blood pressure levels and used their mean to 
detect hypertension. The survey used the guideline of the 
World Health Organization (WHO) to report a participant 
as hypertensive.15 The WHO guideline has integrated the 
2017 guidelines of the American College of Cardiology/
American Society of Hypertension.16 17 According to the 
WHO guideline, a participant with systolic blood pressure 
(SBP) ≥140 mmHg or diastolic blood pressure (DBP) 
≥90 mmHg is diagnosed as a hypertension case. We also 
considered participants as patients with hypertension if 
s/he was previously told by a health professional that they 
have hypertension or if they were already taking medi-
cation to control hypertension. Our outcome variable 
is undiagnosed hypertension. A patient is considered as 
undiagnosed for hypertension if, at the time of the survey, 
s/he was diagnosed as hypertensive (SBP ≥140 mmHg 
or DBP ≥90 mmHg) but never took any prescribed anti- 
hypertensive medicine to lower/control blood pressure 
and was never told by a health professional that they have 
hypertension prior the survey.18 19
Explanatory variables
This study considered a set of sociodemographic and 
behavioural characteristics as independent variables. 
Age (in years), sex, body mass index (BMI) measured 
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through dividing the weight by squared height (kg/m2), 
education level, household wealth status, place of resi-
dence, ecological zone and provinces were considered 
as sociodemographic characteristics of the patients. 
Age was categorised as 15–24, 25–34, 35–44, 45–54, 
55–64 and ≥65 years. Sex had two categories, male and 
female. The BMI was categorised as thin/underweight 
(BMI<18.5 kg/m2), normal (18.5 kg/m2≤BMI<25 kg/
m2) and overweight/obese (BMI≥25.0 kg/m2).20 Based 
on the highest class completed by the respondents, level 
of education was classified as no education, primary, 
secondary and higher. NDHS used principal component 
analysis15 to construct the wealth index and order house-
holds into five socioeconomic quintiles (poorest, poorer, 
middle, richer and richest). The place of residence was 
stratified as urban and rural across all geographic loca-
tions. Nepal was ecologically divided in Mountain, Hill 
and Terai. The seven administrative provinces were 
identified as province 1, province 2, province 3, prov-
ince 4, province 5, province 6 and province 7. Three 
behavioural characteristics of patients, caffeine, tobacco 
and alcohol consumption, were considered as inde-
pendent variables, each of which contained dichoto-
mous response of whether or not the patient consumed 
caffeine, tobacco or alcohol.
Statistical analyses
Using univariate analysis, we described the prevalence 
of undiagnosed hypertension and background char-
acteristics of the study patients. The estimates of each 
of the categorical variables included in this study were 
reported with numbers, weighted percentages and 95% 
confidence interval (CI) of estimates. The weighted 
prevalence of undiagnosed hypertension was deter-
mined across the background characteristics of the study 
patients from bivariate analysis. Statistical significance 
was detected by applying χ2 test. Then, we conducted 
simple and multiple binary logistic regression analyses 
to examine the correlates of undiagnosed hypertension. 
The results of the regression analysis were presented 
in terms of OR with respective 95% CIs. Variables that 
were statistically significant in simple logistic regression 
analysis were entered in the multiple regression model 
to estimate the adjusted OR (AOR). Notably, the statis-
tical significance was defined at 5% level (p value<0.05). 
Variance inflation factors to detect multicollinearity 
among the independent variables were assessed before 
incorporating them into the multiple regression model. 
Due to hierarchical structure of NDHS data, we consid-
ered the cluster sampling design of the 2016 NDHS to 
estimate the prevalence and correlates in this study.15 We 
Figure 1 Selection of participants.
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excluded cases with missing values for blood pressure 
measurements.
Proposed by Wagstaff21 to measure the inequality, 
we estimated the Concentration Index (C), to show 
the degree and direction of wealth- based inequality in 
undiagnosed hypertension prevalence. For the purpose 
of calculating C, the households were ranked from the 
poorest to the richest according to their socioeconomic 
characteristics. We plotted a concentration curve to 
portray the distribution of undiagnosed hypertension. 
The Y- axis of the concentration curve represents the 
cumulative proportion of undiagnosed hypertension and 
the X- axis represents the cumulative proportions of the 
population across wealth quintiles. When the concen-
tration curve coincides with the diagonal, the preva-
lence of undiagnosed hypertension is treated as equally 
distributed across socioeconomic groups. In contrast, the 
concentration curve typically deviates from the diagonal 
if there exists inequalities in the prevalence of undiag-
nosed hypertension. The C is defined as twice the area 
between the concentration curve and the diagonal.22–24 
The index value can range between –1 and +1, a positive 
value implies the prevalence of undiagnosed hyperten-
sion is more concentrated among higher socioeconomic 
status groups and a negative value implies the prevalence 
is more concentrated among lower socioeconomic status 
groups.23 25 We repeated the estimation of C across other 
geographical locations such as place of residence, ecolog-
ical zones and provinces to detect the group of patients 
with the highest severity of socioeconomic inequalities 
in the prevalence of undiagnosed hypertension. STATA 
(version V.13) was used to perform all the analyses.26
Patient and public involvement
Patients and public were not involved in developing the 
research questions, measuring outcome and designing 
the study. Information of the participants was anonymous.
RESULTS
General characteristics of the study patients
Table 1 shows the general characteristics of the study 
patients. Among the patients studied, the average age of 
patients was 49.8 years (95% CI 49.1, 50.5) with the lowest 
percentage of patients in the 15–24 years age group 
(6.6%) and the highest percentage of patients in the 
45–54 years age group (20.9%). The sample was balanced 
among male (49.5%) and female (50.5%) patients. 
Nearly half of the patients were normal in terms of their 
BMI, while more than one- third of the patients were over-
weight/obese. Two- thirds of the patients resided in urban 
areas (64.9%). The educational status of the patients was 
poor with nearly half of the patients having no educa-
tion, while 24.1% and 11.5% had secondary and higher 
education, respectively. The highest number of patients 
belonged to the richest wealth quintile (28.3%) and the 
lowest number of patients belonged to the poorest wealth 
quintile (15.5%). Also, the highest number of patients 
were from province 3 (26.0%) followed by province 5 
(17.8%) and province 1 (17.0%). Only 5.6% of patients 
were from the mountain ecological zone.
Prevalence of undiagnosed hypertension
Of the 3334 patients who had hypertension during 
the survey, more than half of them were detected as 
remaining undiagnosed (50.4%). The prevalence of 
undiagnosed hypertension among the patients varied 
across their age (p- value<0.001), sex (p- value<0.001), 
BMI (p- value<0.001), wealth quintile (p- value<0.001) 
and place of residence (p- value<0.01). The prevalence 
of undiagnosed hypertension was higher among younger 
patients (15–24 years age group) and steadily decreased 
with the increase of age. The prevalence of undiagnosed 
hypertension was higher among male patients (54.2%) 
compared with female patients (46.7%). Compared 
with patients with normal BMI, the prevalence of undi-
agnosed hypertension was higher among patients with 
lower BMI (57.8%) and lower among overweight/obese 
patients (44.4%). Compared with patients of the richest 
wealth quintile (39.6%), the prevalence of undiagnosed 
hypertension was higher among patients of the poorest 
(64.1%) and poorer (55.8%) quintiles. The rate of undi-
agnosed hypertension was higher among rural patients 
(55.2%) compared with urban (47.8%). No educational, 
ecological and provincial variations in the prevalence of 
undiagnosed hypertension were observed (table 1).
Correlates of undiagnosed hypertension
We found that age, sex, BMI, wealth quintile, place of resi-
dence and province were significantly associated with the 
prevalence of undiagnosed hypertension among patients 
with hypertension in unadjusted logistic regression anal-
ysis (see online supplemental table 1).
Figure 2 represents the results of multiple logistic 
regression analysis. The multiple binary logistic regres-
sion model showed that age, sex, BMI, wealth quintile and 
province had a significant association with undiagnosed 
hypertension. Elderly patients (≥65 years of age) had a 
lower likelihood of being undiagnosed for hypertension 
than patients aged 15–24 years (AOR=0.65, 95% CI 0.48, 
0.91). Male patients were 1.29 times more likely than 
female patients to remain undiagnosed for hypertension 
(AOR=1.29, 95% CI 1.11, 1.51). Compared with patients 
with normal BMI, overweight/obese patients (AOR=0.80, 
95% CI 0.69, 0.93) were less likely to have undiagnosed 
hypertension.
We found wealth quintiles as potential correlates of 
undiagnosed hypertension. The risk of remaining undi-
agnosed for hypertension increased with decreasing 
socioeconomic status. Likelihood of having undiagnosed 
hypertension was greater among poorer socioeconomic 
status patients compared with higher socioeconomic 
quintiles. Patients of poorest and poorer wealth quin-
tiles were 2.49 (AOR=2.49; 95% CI 1.90, 3.30) and 1.67 
(AOR=1.67; 95% CI 1.29, 2.16) times more likely to have 
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an undiagnosed hypertension condition than patients of 
the wealthiest quintile.
Moreover, significant provincial variation was evident 
in the prevalence of undiagnosed hypertension among 
hypertensive patients. Patients of province 4 (AOR=1.36, 
95% CI 1.04, 1.79) and province 5 (AOR=1.43, 95% CI 
1.05, 1.95) were more likely to have undiagnosed hyper-
tension than patients of province 1.
Socioeconomic inequalities in undiagnosed hypertension
Figure 3 depicts the inequalities in the prevalence of 
undiagnosed hypertension among hypertensive patients. 
The difference in the distribution of undiagnosed hyper-
tension was 24.6% between the lowest wealth quintile 
(Q1) and highest wealth quintile (Q5), meaning that the 
prevalence of undiagnosed hypertension was greater by 
24.6 percentage points among the poorest patients. The 
Figure 2 Correlates of undiagnosed hypertension among patients with hypertension in Nepal, 2016.
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relative measure of inequality in terms of poor (Q1): rich 
(Q5) ratio was 1.6 for the prevalence of undiagnosed 
hypertension among patients, depicting that the preva-
lence of undiagnosed hypertension was 1.6 times higher 
among the poorest than the richest patients. We found 
negative value of the Concentration Index (C=−0.18), 
which suggests that the prevalence of undiagnosed 
hypertension among patients with hypertension was 
disproportionately distributed among lower socioeco-
nomic status groups.
In addition, patients living in mountain areas and in 
province 7 had large gaps in the prevalence of undiag-
nosed hypertension (figure 4). The higher Q1:Q5 ratio 
was observed among those who had large Q1–Q5 gaps 
in the prevalence of undiagnosed hypertension across 
different geographic locations. We found large negative 
values of C among those who had higher Q1–Q5 gaps and 
Q1:Q5 ratio for the prevalence of undiagnosed hyperten-
sion. See figure 4 for details.
DISCUSSION
Globally, to date, few studies have been conducted on 
undiagnosed hypertension. For the first time, this study 
estimated the prevalence of undiagnosed hypertension 
in Nepal as 50.4% of respondents who tested positive for 
hypertension in the 2016 NDHS. In addition, this study 
identified the risk factors and inequalities associated with 
undiagnosed hypertension in Nepal. The high prevalence 
of undiagnosed hypertension identified in this study may 
be due to people’s lack of awareness and willingness 
to partake in regular health check- ups in the absence 
of health issues, coupled with accessibility barriers to 
screening services.27 Lack of knowledge, attitudes and 
behaviours that promote healthy lifestyles as preventive 
measures to NCDs may also act as a driver of undiagnosed 
Figure 3 Concentration curve to measure the wealth- based 
inequality in the prevalence of undiagnosed hypertension 
among patients with hypertension in Nepal, 2016.
Figure 4 Socioeconomic inequalities in the prevalence of undiagnosed hypertension among patients with hypertension across 
geographical locations in Nepal, 2016.
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hypertension.27–29 Community- based awareness raising of 
changing lifestyles to address the burden of NCDs might 
be effective in reducing this gap.30
Several studies have reported higher risks of hyperten-
sion among people who are older in age, male, urban 
dwellers, have higher education level, regularly consume 
tobacco and/or alcohol, or are overweight.6 8 28 29 We 
found that patients aged ≥65 years and who were over-
weight/obese were at lower risk of remaining undiag-
nosed from hypertension. Our findings depicted a greater 
proportion of undiagnosed hypertensive patients among 
those who were young and those with lower BMI. Young 
or underweight people may be less conscious about 
their health status as they might have the misconception 
that they are less likely to suffer from NCDs.31 In addi-
tion, people from lower socioeconomic status groups in 
Nepal tend to have less knowledge and awareness about 
health hazards, typically have poorer access to services 
for screening diseases and lack the capacity to afford 
treatment costs for diseases.28 This may contribute to the 
disproportionate occurrence of undiagnosed hyperten-
sion among lower socioeconomic status groups in Nepal.
Similar to risk factors of hypertension, undiagnosed 
hypertension was also more prevalent among males and 
tobacco users.6 29 The higher rate of undiagnosed hyper-
tension among males might be due to their lack of aware-
ness and lower treatment rates than females.32 Smoking, 
a main source of using tobacco, is well recognised to be 
associated with an increased risk of hypertension in many 
settings, including Nepal.33 34 However, there is a lack of 
evidence to determine the extent to which tobacco use 
is related to patients remaining undiagnosed for hyper-
tension. Our findings demonstrate that, in Nepal, factors 
other than tobacco use played independent roles in 
predicting the rate of undiagnosed hypertension. While 
differences in lifestyle practices between males and 
females in Nepal may be a key factor behind different 
exposures, further research is needed to identify the 
actual risk factors.29
Undiagnosed hypertension may lead to adverse health 
consequences, including organ damage.35 The WHO, 
denoting hypertension as a silent killer, stated that the 
prevalence of hypertension is higher in low- income and 
middle- income countries compared with developed and 
high- income countries.3 Our results support this claim 
and also align with findings from Bangladesh and sub- 
Saharan Africa.19 36 37 Despite being neighbouring coun-
tries, the prevalence of undiagnosed hypertension from 
this study (approximately 50%) is much higher than 
that of China.38 For example, recent evidence shows that 
the prevalence of undiagnosed hypertension in China 
is 28.8%.39 The reason behind this difference might be 
due to the differences in the age of study participants. 
Our study assessed participants of age 15 years or older 
in Nepal, while the Chinese study included older partic-
ipants (over 45 years) who may be more aware of health 
conditions and more likely to visit doctors for regular 
health check- ups. Findings from studies conducted in 
countries with more developed healthcare systems and 
advanced screening processes such as Japan, Korea, 
England, Ireland, Egypt, Brazil and the USA were also 
found to have lower levels of undiagnosed hypertension 
than Nepal as found in this study.40–46 The prevalence of 
undiagnosed hypertension in Nepal is relatively closer 
with that of Bangladesh.19 This might be due to the less 
advanced healthcare systems of these two countries with 
both countries displaying low Health Care Index values.38
In Nepal, despite the detection of risk factors6 8 29 and 
inequalities,28 the prevalence of hypertension has been 
well investigated nationally, resulting in the implemen-
tation of new policies to mitigate the rising number of 
patients with hypertension.47 However, these policy 
reform efforts will fail to effectively achieve intended 
hypertension reduction targets if patients remain undi-
agnosed, undetected and untreated. It is necessary to 
identify whether the unequal distribution of undiagnosed 
hypertension exists among patients with hypertension 
across different socioeconomic groups. Such informa-
tion will aid in setting priorities and effective allocation 
of resources. Our study reveals the existence of inequali-
ties in the distribution of undiagnosed hypertension due 
to economic status. Lower socioeconomic status groups 
experienced a higher prevalence of undiagnosed hyper-
tension compared with higher socioeconomic groups and 
a greater degree of wealth- based inequality was concen-
trated among the poorest. These inequalities were more 
prevalent among patients living in different geographical 
locations including place of residence, ecological zones 
and administrative provinces. Such disparities may be 
owing to greater awareness of health issues and more 
utilisation of healthcare services among higher socioeco-
nomic groups.28 Such inequality might increase the cata-
strophic health spending, given the rise of catastrophic 
household expenditure due to NCDs in Nepal.14 48 Public 
health strategies might reduce this gap by concentrating 
more on implementing social health insurance policies 
which are equitable for all.40 48 In this respect, policy-
makers could take into consideration the disparities in 
the distribution of undiagnosed hypertension found in 
this study.
Several initiatives have been taken to control hyperten-
sion in Nepal. To address the burden of CVD, the WHO 
and partners launched an initiative called ‘Global Hearts’ 
in 2016.49 This initiative took a comprehensive approach 
to help countries in scaling- up affordable and adaptable 
measures to improve the capacity of healthcare services to 
better detect and treat people at risk of or suffering from 
CVD. This initiative comprises three packages: SHAKE, 
HEARTS and MPOWER. The package ‘HEARTS’ provides 
tools to incorporate CVD management best practices at 
the primary healthcare level to reduce CVD risk factors 
such as hypertension and high blood cholesterol. Like 
many low to middle incomes countries, Nepal has adapted 
the Global Hearts initiative to address CVD. In addition, 
the Community- Based Management of Hypertension in 
Nepal is a community- based cost- effective intervention 
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with demonstrated success in reducing hypertension in 
Nepal.50 51 However, for designing future programmes 
or interventions for the prevention of hypertension in 
Nepal, our findings highlight the importance of consid-
ering undiagnosed hypertensive cases and the uneven 
distribution of such cases across a spectrum of sociode-
mographic characteristics.
Failing to diagnose and detect hypertension among 
vulnerable populations will have detrimental health 
outcomes for any nation. This study, for the first time at 
a national level, sheds light on the prevalence of undiag-
nosed hypertension in Nepal. The NDHS 2016, through 
the incorporation of biomarker tests, bears evidence 
that a substantial proportion of individuals are suffering 
from blood pressure abnormalities. This emphasises the 
need for conducting routine screening for hypertension 
that ensures access by lower socioeconomic groups and 
at risk populations. A routine surveillance system with 
technology- based screening can aid in tracing disease 
incidence including among people at risk of being 
undiagnosed.52 Our study findings will help inform and 
initiate policies and programmes that capture the highest 
domain of vulnerable populations and bring them under 
routine surveillance at the community level with optimal 
cost.
Strengths and limitations
We used the most updated, nationally representa-
tive, cross- sectional data to determine the prevalence, 
correlates and inequalities of undiagnosed hypertension 
in Nepal. We considered the complex survey design in 
our methods and captured variations. However, there 
may be residuals and unmeasured behavioural or lifestyle 
factors potentially relevant to undiagnosed hypertension, 
for example, physical activity, dietary patterns and family 
history of hypertension, that were not explored in this 
study. Since our data were cross- sectional, the relationship 
between undiagnosed hypertension and confounders 
were probabilistic rather than causal. However, identifi-
cation of potential correlates through using OR is widely 
acceptable. This study measured both absolute and 
relative inequalities in the prevalence of undiagnosed 
hypertension at national level as well as across place of 
residence, ecological zones and administrative provinces 
to further guide policy/decision makers for better alloca-
tion of resources to reduce hypertension rates.
CONCLUSIONS
For the first time on a national level in Nepal, this study 
estimates the prevalence of undiagnosed hypertension 
as 50.4% of respondents who tested positive for hyper-
tension in the NDHS. Furthermore, our results show that 
the prevalence of undiagnosed hypertension is dispro-
portionately higher among lower socioeconomic status 
groups in Nepal. Our results suggest that efforts should 
be made to improve the knowledge, attitudes and prac-
tices of people around hypertension, particularly among 
those who are young, slender, poor and male, given their 
higher risk of being undiagnosed. Routine screening 
and strengthening the diagnosis of hypertension in the 
primary level of healthcare service facilities may help 
Nepal in reducing cases with undiagnosed hypertension. 
Moreover, identification of inequalities among different 
risk groups will be beneficial in achieving the universal 
health coverage target of the United Nations Sustainable 
Development Goals (Goal 3.8.1). Social health insurance 
policies under an integrated national NCD policy should 
be properly enacted to ensure socioeconomically disad-
vantaged populations are adequately covered under the 
scheme for the prevention and control of hypertension.
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